A new screening technique, MR fusion guided prostate biopsy, holds promise for increased prostate cancer detection.
By 2024, the number of Americans with a history of cancer is expected to grow to 19 million.
Researchers have developed a breathalyzer that can detect lung cancer and assess whether it is early or advanced, according to findings presented at the 2014 annual meeting of the American Society of Clinical Oncology.
Panel distinguishes early cancer from healthy controls, chronic pancreatitis, benign cysts
Panels of microRNA expression can potentially distinguish pancreatic cancer from healthy controls, according to a study.
New findings that run counter to federal recommendations indicate that women should be encouraged to initiate regular mammographic screening before age 50 years.
Free screenings for head and neck cancer can increase early detection and provide an opportunity to educate people about risk factors. But who is most likely to attend these screenings, and what do attendees know about head and neck cancer?
Most deaths from breast cancer occur in younger women who do not receive regular mammograms, according to a new study. The study indicates that regular screening before age 50 years should be encouraged.
A new screening strategy for ovarian cancer appears to be highly specific for detecting the disease before it becomes lethal, according to a new study.
Carbohydrate antigen 125 (CA125) testing, already used to predict ovarian cancer recurrence, has now shown strong results as a screening technique for early-stage disease when combined with transvaginal ultrasound.
Algorithm is used to estimate risk of ovarian cancer in postmenopausal women and demonstrates high specificity.
A considerable proportion of children with melanoma do not present with conventional ABCDE detection criteria.
A telephone outreach intervention delivered by Medicaid managed care organization (MMCO) staff can increase rates of colorectal cancer (CRC) screening among women overdue for screening, according to a study.
Mothers commonly talk to their children about genetic test results even if they test positive for a BRCA1 or BRCA2 gene mutation, which sharply increases a woman's risk of developing breast and ovarian cancer.
Researchers have identified a biomarker for colorectal cancer that can be obtained from a small amount of serum DNA in less than 1 mL of blood and that is highly sensitive and specific for the disease.
Digital chest tomosynthesis holds promise as a first-line tool for lung cancer screening, according to the baseline results of a single-arm, observational study.
Next generation genomic analysis has determined that some of the more aggressive prostate cancers have similar genetic origins, according to a recent publication
Digital direct radiography is significantly more effective than computed radiography at detecting breast cancer, according to a new study.
Exposure to Agent Orange has been linked to lethal forms of prostate cancer among US veterans by a new analysis.
Digital breast tomosynthesis may be more accurate than mammography but with greater radiation exposure, additional study comparing the detection methods would be beneficial.
Patients at higher or lower risk for having their cancer recur elsewhere in the body more than 5 years after diagnosis can be differentiated by a gene expression test. The test measures the expression levels of 58 genes in estrogen receptor-positive breast cancers. These research results were presented at the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium.
Initial results confirm more positive screening results, diagnostic procedures, cancer ID'd with CT versus standard chest X-rays.
Pioneering biophotonics technology is the first screening method to detect the early presence of ovarian cancer in humans
Integrated 2-dimensional (2D) and 3-dimensional (3D) mammography improves the detection of breast cancer and reduces false-positive findings.
Computer-aided detection helped find more cases of noninvasive breast cancer, but also led to more unnecessary testing in the absence of disease.
Older adults undergo cancer screening even when unlikely to benefit and when at risk of harm, but stopping screening is not discussed.
A new diagnostic test that uses the technique of metabolomic analysis may be a safe and easy screening method that could improve the prognosis of patients with pancreatic cancer through earlier detection.
Women 50 to 74 who have mammography every 2 years have similar risk of advanced disease as, and fewer false-positives than, annual screeners.
A recent study uncovered adenoma detection rates significantly higher than those set in national guidelines.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|